Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF.

Subjects

Subjects :

Humans
Tyrosine Kinase Inhibitors
Czech Republic
Chronic Disease
Protein Kinase Inhibitors therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Leukemia, Myeloid

Details

Language :

English

ISSN :

1476-5551

Volume :

38

Issue :

4

Database :

MEDLINE

Journal :

Leukemia

Publication Type :

Academic Journal

Accession number :

38472478

Full Text :

https://doi.org/10.1038/s41375-024-02215-9